Compare Aegon Ltd. (AEG) vs Ascendis Pharma A/S (ASND) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Aegon Ltd. vs Ascendis Pharma A/S — how do they compare? Aegon Ltd. trades at $9.45 (market cap $14.01B), while Ascendis Pharma A/S trades at $254.5 (market cap $16.67B). The key difference: Ascendis Pharma A/S is the larger of the two by market cap, and Aegon Ltd. pays a 4.94% dividend while Ascendis Pharma A/S pays none. Which is the better fit depends on your goals.
| AEG | ASND | |
|---|---|---|
Market Cap | $14.01B | $16.67B |
Sector | Financials | Health |
52-Week High | $9.53 | $277.18 |
52-Week Low | $6.79 | $189.74 |
Enterprise Value | $15.16B | $17.04B |
Dividend Yield | 4.94% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Aegon Ltd.
Aegon is a Netherlands-headquartered insurance company with core operations that stretch across the U.S., Netherlands, and United Kingdom. The business also holds peripheral ventures in Spain, Portugal, Brazil, and China.
Read more on AEG →About Ascendis Pharma A/S
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →
